Results 11 to 20 of about 60,451 (335)

The Evolving Role of Antifungal Susceptibility Testing [PDF]

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/98278/1/phar1233 ...
Carver, Peggy L., Eschenauer, Gregory A.
core   +5 more sources

ASSESSMENT OF SPECIATION AND ANTIFUNGAL SUSCEPTIBILITY TESTING IN THE INTENSIVE CARE UNIT: AN OBSERVATIONAL CROSS-SECTIONAL STUDY DESIGN.

Student's Journal of Health Research Africa, 2023
Objectives:  This study aims to investigate the epidemiology of Candidemia in patients admitted to Intensive Care Units (ICUs), focusing on the distribution of species, antifungal susceptibility patterns, and demographic factors.
Bhuvan Shome, Ashok Kumar Sharma, Kumari Seema, Abhay Kumar, Manoj Kumar, Manju Boipai   +5 more
doaj   +3 more sources

New approaches for antifungal susceptibility testing [PDF]

Clinical Microbiology and Infection, 2017
Invasive fungal diseases, including those caused by (multi)drug-resistant Candida and Aspergillus species, still represent global public health concerns. Information about the antifungal susceptibility testing (AFST) of fungal isolates must be quickly produced to help clinicians in administrating appropriate antifungal therapies.
Maurizio Sanguinetti, Brunella Posteraro   +1 more
exaly   +3 more sources

When Should Clinical Mycology Laboratories Perform Antifungal Susceptibility Testing? Revisiting Practice Through the Lens of Intrinsic Resistance. [PDF]

Mycopathologia
Lass-Flörl C, Arikan-Akdagli S.
europepmc   +3 more sources

Antifungal Susceptibility Testing - The Times They Are a Changin'. [PDF]

Clin Microbiol Newsl, 2019
Antifungal susceptibility testing (AFST) has never been as mainstream as antibacterial susceptibility testing. That may soon change. We are in an unprecedented era of antifungal development which could change the usefulness of and demand for AFST. Here we lay out an argument for increased AFST capacity, discuss new antifungals that are likely to appear
Lockhart SR, Berkow EL.
europepmc   +3 more sources

P-1607. Comparison of In-House Versus Reference Laboratory Antifungal Susceptibility Testing on De-Escalation Rates of Echinocandin Therapy for Candidemia [PDF]

Open Forum Infect Dis
J. L. Webb, Kristin Mondy, Theresa Jaso, Dusten T. Rose   +3 more
europepmc   +2 more sources

Comparative evaluation of antifungal susceptibility testing methods of invasive Candida species and detection of FKS genes mutations in caspofungin intermediate and resistant isolates. [PDF]

BMC Infect Dis
ElFeky DS, El-Wakil DM, Mwafy MM, Atia MMA, Gohar NM.   +4 more
europepmc   +3 more sources

Low utilization of epidemiological cutoff values to interpret in vitro antifungal susceptibility testing among clinical laboratory participants in two College of American Pathologists (CAP) proficiency testing programs. [PDF]

J Clin Microbiol
Sullivan KV, Long T, Hillesland E, Rhoads DD, Wojewoda CM, Zhang SX.   +5 more
europepmc   +3 more sources

Antifungal susceptibility testing following the CLSI M27 document, along with the measurement of MFC/MIC ratio, could be the optimal approach to detect amphotericin B resistance in Clavispora (Candida) lusitaniae. Susceptibility patterns of contemporary isolates of this species. [PDF]

Antimicrob Agents Chemother, 2023
Sasoni N, Caracciolo B, Cabeza MS, Gamarra S, Carnovale S, Garcia-Effron G.   +5 more
europepmc   +3 more sources

Antifungal susceptibility testing [PDF]

Clinical Microbiology Reviews, 1993
Unlike antibacterial susceptibility testing, reliable antifungal susceptibility testing is still largely in its infancy. Many methods have been described, but they produce widely discrepant results unless such factors as pH, inoculum size, medium formulation, incubation time, and incubation temperature are carefully controlled.
J H, Rex, M A, Pfaller, M G, Rinaldi, A, Polak, J N, Galgiani   +4 more
openaire   +3 more sources